Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer (Q39661572)
Jump to navigation
Jump to search
scientific article published on 30 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer |
scientific article published on 30 August 2010 |
Statements
1 reference
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer (English)
1 reference
Jagath R Junutula
1 reference
Kelly M Flagella
1 reference
Richard A Graham
1 reference
Kathryn L Parsons
1 reference
Edward Ha
1 reference
Helga Raab
1 reference
Sunil Bhakta
1 reference
Trung Nguyen
1 reference
Debra L Dugger
1 reference
Guangmin Li
1 reference
Elaine Mai
1 reference
Gail D Lewis Phillips
1 reference
Hajime Hiraragi
1 reference
Reina N Fuji
1 reference
Jay Tibbitts
1 reference
Richard Vandlen
1 reference
Susan D Spencer
1 reference
Richard H Scheller
1 reference
Paul Polakis
1 reference
Mark X Sliwkowski
1 reference
30 August 2010
1 reference
1 reference
4769-4778
1 reference
Identifiers
1 reference